The firm bought Netherlands-based itemedical for €23m (£20m) and Sweden’s Naslund Medical for $45m (£34m) both on a cash and debt free basis.
Itemedical makes digital platforms that integrates real-time patient data and alarms from different medical devices, supporting clinical decision-making and workflow efficiency in hospitals.
Naslund Medical specialises in fiducial marker technology used to support targeted cancer treatment. Its core product, Gold Anchor, enables more precise targeting of tumours during radiation therapy. Halma said.
Reporting by Frank Prenesti for Sharecast.com